Literature DB >> 17363190

Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer.

Yukinori Matsuo1, Kenji Takayama, Yasushi Nagata, Etsuo Kunieda, Kunihiko Tateoka, Naoki Ishizuka, Takashi Mizowaki, Yoshiki Norihisa, Masato Sakamoto, Yuichiro Narita, Satoshi Ishikura, Masahiro Hiraoka.   

Abstract

PURPOSE: The aim of this study was to assess interinstitutional variations in planning for stereotactic body radiation therapy (SBRT) for lung cancer before the start of the Japan Clinical Oncology Group (JCOG) 0403 trial. METHODS AND MATERIALS: Eleven institutions created virtual plans for four cases of solitary lung cancer. The created plans should satisfy the target definitions and the dose constraints for the JCOG 0403 protocol.
RESULTS: FOCUS/XiO (CMS) was used in six institutions, Eclipse (Varian) in 3, Cadplan (Varian) in one, and Pinnacle3 (Philips/ADAC) in one. Dose calculation algorithms of Clarkson with effective path length correction and superposition were used in FOCUS/XiO; pencil beam convolution with Batho power law correction was used in Eclipse and Cadplan; and collapsed cone convolution superposition was used in Pinnacle3. For the target volumes, the overall coefficient of variation was 16.6%, and the interinstitutional variations were not significant. For maximal dose, minimal dose, D95, and the homogeneity index of the planning target volume, the interinstitutional variations were significant. The dose calculation algorithm was a significant factor in these variations. No violation of the dose constraints for the protocol was observed.
CONCLUSION: There can be notable interinstitutional variations in planning for SBRT, including both interobserver variations in the estimate of target volumes as well as dose calculation effects related to the use of different dose calculation algorithms.

Entities:  

Mesh:

Year:  2007        PMID: 17363190     DOI: 10.1016/j.ijrobp.2006.12.012

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

Review 1.  Impact of dose calculation algorithm on radiation therapy.

Authors:  Wen-Zhou Chen; Ying Xiao; Jun Li
Journal:  World J Radiol       Date:  2014-11-28

Review 2.  Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

Authors:  Tejan P Diwanji; Pranshu Mohindra; Melissa Vyfhuis; James W Snider; Chaitanya Kalavagunta; Sina Mossahebi; Jen Yu; Steven Feigenberg; Shahed N Badiyan
Journal:  Transl Lung Cancer Res       Date:  2017-04

Review 3.  Radiation pneumonitis after stereotactic radiation therapy for lung cancer.

Authors:  Hideomi Yamashita; Wataru Takahashi; Akihiro Haga; Keiichi Nakagawa
Journal:  World J Radiol       Date:  2014-09-28

4.  Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer.

Authors:  Kiyotomo Matsugi; Mitsuhiro Nakamura; Yuki Miyabe; Chikako Yamauchi; Yukinori Matsuo; Takashi Mizowaki; Masahiro Hiraoka
Journal:  Radiol Phys Technol       Date:  2012-12-18

5.  Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy.

Authors:  Hideomi Yamashita; Shino Kobayashi-Shibata; Atsuro Terahara; Kae Okuma; Akihiro Haga; Reiko Wakui; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2010-05-09       Impact factor: 3.481

6.  Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.

Authors:  Ying Xiao; Lech Papiez; Rebecca Paulus; Robert Timmerman; William L Straube; Walter R Bosch; Jeff Michalski; James M Galvin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

Review 7.  Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases.

Authors:  Enrique Gutiérrez; Irving Sánchez; Omar Díaz; Adrián Valles; Ricardo Balderrama; Jesús Fuentes; Brenda Lara; Cipatli Olimón; Víctor Ruiz; José Rodríguez; Luis H Bayardo; Matthew Chan; Conrad J Villafuerte; Jerusha Padayachee; Alexander Sun
Journal:  Curr Oncol       Date:  2021-07-15       Impact factor: 3.677

8.  Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors.

Authors:  Masaru Narabayashi; Takashi Mizowaki; Yukinori Matsuo; Mitsuhiro Nakamura; Kenji Takayama; Yoshiki Norihisa; Katsuyuki Sakanaka; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2012-07-13       Impact factor: 2.724

9.  Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.

Authors:  Takahisa Eriguchi; Atsuya Takeda; Yohei Oku; Satoshi Ishikura; Tomoki Kimura; Shuichi Ozawa; Takeo Nakashima; Yukinori Matsuo; Mitsuhiro Nakamura; Yasuo Matsumoto; Sadanori Yamazaki; Naoko Sanuki; Yoshinori Ito
Journal:  Radiat Oncol       Date:  2013-05-04       Impact factor: 3.481

10.  Evaluation of Auto-Planning for Left-Side Breast Cancer After Breast-Conserving Surgery Based on Geometrical Relationship.

Authors:  Yijiang Li; Han Bai; Danju Huang; Feihu Chen; Yaoxiong Xia
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.